肿瘤科

订阅

MedSci主页 / 所有栏目 / 肿瘤科

HER2阳性早期乳腺癌的标准治疗选择是什么？

2021-07-06 MedSci原创 MedSci原创

乳腺癌
关注

梅斯直播课：乳腺癌诊疗训练营 聂建云老师回答问题：HER2阳性早期乳腺癌的标准治疗选择是什么？

梅斯直播课：乳腺癌诊疗训练营
聂建云老师回答问题：HER2阳性早期乳腺癌的标准治疗选择是什么？

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1948277, encodeId=ca7c19482e722, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61937, encryptionId=c04b6193ee0, topicName=标准治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Tue Jan 04 10:44:49 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772748, encodeId=1dee1e72748ae, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Wed Nov 03 19:44:49 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998245, encodeId=39139982453e, content=理学标准治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Sat Jul 10 18:32:19 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308598, encodeId=732d130859854, content=<a href='/topic/show?id=240f8e3234' target=_blank style='color:#2F92EE;'>#HER2阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8732, encryptionId=240f8e3234, topicName=HER2阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8409354, createdName=闆锋旦, createdTime=Thu Jul 08 00:44:49 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996841, encodeId=326e9968411c, content=好！sjdnxndbdj, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/0c978667dfd64fbf95596936f479ba10/c5864885126e4ddbb9339d5d4f38d83b.jpg, createdBy=d3f0104488, createdName=gz900223, createdTime=Tue Jul 06 15:49:36 CST 2021, time=2021-07-06, status=1, ipAttribution=)]
    2022-01-04 小小小向日葵

    #标准治疗#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1948277, encodeId=ca7c19482e722, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61937, encryptionId=c04b6193ee0, topicName=标准治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Tue Jan 04 10:44:49 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772748, encodeId=1dee1e72748ae, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Wed Nov 03 19:44:49 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998245, encodeId=39139982453e, content=理学标准治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Sat Jul 10 18:32:19 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308598, encodeId=732d130859854, content=<a href='/topic/show?id=240f8e3234' target=_blank style='color:#2F92EE;'>#HER2阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8732, encryptionId=240f8e3234, topicName=HER2阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8409354, createdName=闆锋旦, createdTime=Thu Jul 08 00:44:49 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996841, encodeId=326e9968411c, content=好！sjdnxndbdj, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/0c978667dfd64fbf95596936f479ba10/c5864885126e4ddbb9339d5d4f38d83b.jpg, createdBy=d3f0104488, createdName=gz900223, createdTime=Tue Jul 06 15:49:36 CST 2021, time=2021-07-06, status=1, ipAttribution=)]
    2021-11-03 liye789132264

    #治疗选择#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1948277, encodeId=ca7c19482e722, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61937, encryptionId=c04b6193ee0, topicName=标准治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Tue Jan 04 10:44:49 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772748, encodeId=1dee1e72748ae, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Wed Nov 03 19:44:49 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998245, encodeId=39139982453e, content=理学标准治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Sat Jul 10 18:32:19 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308598, encodeId=732d130859854, content=<a href='/topic/show?id=240f8e3234' target=_blank style='color:#2F92EE;'>#HER2阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8732, encryptionId=240f8e3234, topicName=HER2阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8409354, createdName=闆锋旦, createdTime=Thu Jul 08 00:44:49 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996841, encodeId=326e9968411c, content=好！sjdnxndbdj, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/0c978667dfd64fbf95596936f479ba10/c5864885126e4ddbb9339d5d4f38d83b.jpg, createdBy=d3f0104488, createdName=gz900223, createdTime=Tue Jul 06 15:49:36 CST 2021, time=2021-07-06, status=1, ipAttribution=)]
    2021-07-10 ms3000001999514966

    理学标准治疗

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1948277, encodeId=ca7c19482e722, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61937, encryptionId=c04b6193ee0, topicName=标准治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Tue Jan 04 10:44:49 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772748, encodeId=1dee1e72748ae, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Wed Nov 03 19:44:49 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998245, encodeId=39139982453e, content=理学标准治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Sat Jul 10 18:32:19 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308598, encodeId=732d130859854, content=<a href='/topic/show?id=240f8e3234' target=_blank style='color:#2F92EE;'>#HER2阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8732, encryptionId=240f8e3234, topicName=HER2阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8409354, createdName=闆锋旦, createdTime=Thu Jul 08 00:44:49 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996841, encodeId=326e9968411c, content=好！sjdnxndbdj, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/0c978667dfd64fbf95596936f479ba10/c5864885126e4ddbb9339d5d4f38d83b.jpg, createdBy=d3f0104488, createdName=gz900223, createdTime=Tue Jul 06 15:49:36 CST 2021, time=2021-07-06, status=1, ipAttribution=)]
    2021-07-08 闆锋旦

    #HER2阳性#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1948277, encodeId=ca7c19482e722, content=<a href='/topic/show?id=c04b6193ee0' target=_blank style='color:#2F92EE;'>#标准治疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=61937, encryptionId=c04b6193ee0, topicName=标准治疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=72bf2500198, createdName=小小小向日葵, createdTime=Tue Jan 04 10:44:49 CST 2022, time=2022-01-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1772748, encodeId=1dee1e72748ae, content=<a href='/topic/show?id=871064e139b' target=_blank style='color:#2F92EE;'>#治疗选择#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64713, encryptionId=871064e139b, topicName=治疗选择)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=015a38388258, createdName=liye789132264, createdTime=Wed Nov 03 19:44:49 CST 2021, time=2021-11-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=998245, encodeId=39139982453e, content=理学标准治疗, beContent=null, objectType=article, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=62a85535130, createdName=ms3000001999514966, createdTime=Sat Jul 10 18:32:19 CST 2021, time=2021-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1308598, encodeId=732d130859854, content=<a href='/topic/show?id=240f8e3234' target=_blank style='color:#2F92EE;'>#HER2阳性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8732, encryptionId=240f8e3234, topicName=HER2阳性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8409354, createdName=闆锋旦, createdTime=Thu Jul 08 00:44:49 CST 2021, time=2021-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996841, encodeId=326e9968411c, content=好！sjdnxndbdj, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210706/0c978667dfd64fbf95596936f479ba10/c5864885126e4ddbb9339d5d4f38d83b.jpg, createdBy=d3f0104488, createdName=gz900223, createdTime=Tue Jul 06 15:49:36 CST 2021, time=2021-07-06, status=1, ipAttribution=)]
    2021-07-06 gz900223

    好！sjdnxndbdj

    0

相关资讯

Br J Cancer：定量乳腺密度分析可改善乳腺癌的筛查方案

分层或基于风险的乳腺癌筛查旨在优化早期癌症的检测，降低患者的死亡率、乳房X光检查假阳性率、良性活检以及过度诊断等。

Molecular Cell:难治性乳腺癌的潜在药物靶点：RNA结合蛋白YTHDF2

研究员发现破坏 YTHDF2 依赖性 mRNA 降解会触发三阴性乳腺癌 (TNBC) 细胞和肿瘤的细胞凋亡。

Circulation：蒽环类药物抗癌治疗的同时，需要预防“伤心”吗？

蒽环类乳腺癌辅助治疗和放疗与癌症治疗相关的心功能不全有关

Ecancermedicalscience :阿司匹林可将癌症患者的死亡风险降低 20%

患有多种癌症的患者将阿司匹林作为治疗的一部分，可以帮助将他们的死亡风险降低 20%。

JCEM：绝经前妇女乳腺癌危险因素和抗苗勒管激素浓度之间的相关性分析

该研究是针对一般人群（不伴有不孕症）女性AMH和乳腺癌危险险因素之间相关性的最大研究，并发现大多数关联仅限于40岁以上、接近更年期且AMH浓度正在下降的女性。

Front Cell Dev Biol：富含Omega-3脂肪酸的母亲饮食可以保护后代免受乳腺癌的侵害

富含菜籽油的母体饮食表观遗传调节转录表达并表观遗传增强各种基因，可能是为了在发生致癌性损伤时快速激活以防止乳腺肿瘤的发展。

拓展阅读

英国NICE支持罗氏的ADC药物Kadcyla恩美曲妥珠单抗，治疗HER2阳性的早期乳腺癌

在使用紫杉烷和靶向HER2的新辅助疗法后仍残留癌细胞的患者中，与单独使用曲妥珠单抗相比，Kadcyla延长了患者无疾病状态的时间。